SRFP074: Participants’ Experience in using a Point of Care Rapid Antigen Test (RAT) for SARS-CoV-2 (Pearls)

Innocent Ndateba, MN, MPH, RN; Michael Schwandt, MD, FRCPC, MPH; Elizabeth Saewyc, PhD, RN, FSAHM, FCAHS, FAAN, FCAN; Don Sin, MD, MPH; Erica Tobias, BSc, BSN, RN; Sabrina Wong, PhD, RN; kristen haase; Manon Ranger, PhD, RN

Abstract

Learning objectives:
On completion of this presentation, participant should be able to:
 Understand the feasibility of RAT for SARS-CoV-2 screening in primary care
 Understand the role of RAT for SARS-CoV-2 screening in prevention of COVID-19 transmission in community
Context: The COVID-19 pandemic has paralyzed human interactions worldwide. At least half of COVID-19 transmissions could originate from asymptomatic individuals. Rapid Antigen Testing (RAT) with nasal sampling at the point of care is inexpensive, fast and less invasive than PCR testing. Objective: The overall study objective was to examine the feasibility of point-of-care RAT for detecting SARS-CoV-2 amongst an asymptomatic population living in congregate housing. Design: Cross-sectional survey. Setting: This study was conducted at the University of British Columbia (UBC). Approximately 1500 undergraduate student were at the study site during February-April 2021. Population: Students living in UBC housing and staff working in the UBC housing sites were eligible. People testing positive for COVID-19 in the prior 90 days were excluded from the study. Intervention: The BD Veritor testing kit was used to test bilateral nasal specimens. Results were ready by the small BD Veritor reader. Outcome measures: Experiences of surveyed participants completing RAT. The survey was conducted during the last three weeks the site was open. Results: A total of 223 participants consisting of 134 (60%) females and 89 (40%) males completed the survey for a 37% response rate. Participants were mainly of European descent (45%), though there were East Asians (18%), African/ Caribbean (5%) and Indigenous (3%) people who also completed the survey. Almost all (98%) reported that RAT was acceptable/very acceptable and 97% would take another test. Participants believed they would test negative given their careful observation of public health measures such as hand washing, mask wearing and restricting contacts to their small “bubble”. Their expectation of testing negative was based on having no or minimal interactions with any person who had tested positive. More than two thirds of participants reported RAT provide them peace of mind and reduced anxiety levels. Participants found the RAT to be safe, easy, accessible and rapid. Conclusions: Rapid antigen testing for detecting COVID-19 is well accepted and could support the detection of infection at an early stage amongst asymptomatic individuals while easing their worries
Leave a Comment
Jack Westfall
jwestfall@aafp.org 11/21/2021

Great poster and abstract. Thanks for sharing at NAPCRG

Gillian Bartlett
gillian.bartlett@health.missouri.edu 11/21/2021

Innocent - great to 'see' your work - very nicely done. I think addressing anxiety is very important and an often overlooked benefit to rapid testing.

William R. Phillips
wphllps@uw.edu 11/22/2021

Beautiful poster describing a great study on this timely and important topic. I like the way you used the participant quotations in the middle panel to personalize the results. What did you learn in the process of this study in this UBC student population with the Covid test that could help us design such effective programs for other problems in the primary care setting? Thanks for sharing your work here at NAPCRG. - Bill Phillips

Diane Harper
harperdi@med.umich.edu 11/22/2021

good work Thank you for sharing your work with NAPCRG!

Andy Pasternak
avpiv711@sbcglobal.net 11/27/2021

Great topic. Glad to see research showing the effectiveness of this as we'll likely be doing this for a while

Social Media

Address

NAPCRG
11400 Tomahawk Creek Parkway
Leawood, KS 66211
800.274.7928
Email: napcrgoffice@napcrg.org